A phase I study of the combination of intravenous Reolysin (REO) and gemcitabine (GEM) in patients (pts) with advanced cancer

H-T Arkenau,Joseph L. Evans,M Lokelma,Patricia Roxburgh,R. Morisson,M Coffey,George M. Gill,K. Mettinger,Brad Thompson,J. de Bono

A phase I study of the combination of intravenous Reolysin (REO) and gemcitabine (GEM) in patients (pts) with advanced cancer

2009

H-T Arkenau
Joseph L. Evans
M Lokelma
Patricia Roxburgh
R. Morisson
M Coffey
George M. Gill
K. Mettinger
Brad Thompson
J. de Bono

3584 Background: REO (reovirus serotype 3) is a Dearing strain, naturally occurring, non-enveloped virus with limited pathogenecity in humans. REO replicates specifically in transformed Ras-activat...

Keywords:

World Wide Web
Cancer research
Reolysin
Cancer
Gemcitabine
Computer science
phase i study
Serotype
Virus
in patient
advanced cancer
Virology
Medicine
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations